Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 5 |
| List of Tables | 4 | 2 |
| List of Figures | 6 | 1 |
| Fresenius SE &Co. KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 6 | 2 |
| Fresenius SE &Co. KGaA, Medical Equipment Deals By Type, 2010 to YTD 2016 | 8 | 1 |
| Fresenius SE &Co. KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 9 | 1 |
| Fresenius SE &Co. KGaA, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 10 | 1 |
| Fresenius SE &Co. KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 11 | 3 |
| Fresenius SE &Co. KGaA, Medical Equipment, Deal Details | 14 | 50 |
| Asset Purchase | 14 | 1 |
| Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson | 14 | 1 |
| Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International | 15 | 2 |
| Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics | 17 | 1 |
| Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro | 18 | 2 |
| Fresenius USA Completes Acquisition Of Assets Of Xcorporeal And National Quality Care | 20 | 2 |
| Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical | 22 | 1 |
| Fresenius Medical Care Acquires Dialysis Stations From Hand Prod | 23 | 1 |
| Partnerships | 24 | 1 |
| Fresenius Medical Care Extends Licensing Agreement with Interface Biologics | 24 | 1 |
| Debiotech and Fresenius Medical Care Enter into Agreement | 25 | 1 |
| Verax Biomedical Renews its Commercialization Agreement with Fresenius Kabi USA | 26 | 1 |
| Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care | 27 | 1 |
| Toray Industries Enters into Distribution Agreement with Fresenius Medical Care | 28 | 1 |
| HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal | 29 | 1 |
| Fenwal Enters Into Co-Marketing Agreement With Applied Science | 30 | 1 |
| JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles | 31 | 1 |
| Fenwal Enters Into Co-Marketing Agreement With Biolog-id For RFID Blood Tracking System | 32 | 1 |
| Fenwal Enters Into Co-Marketing Agreement With Genesis BPS | 33 | 1 |
| Fenwal Signs An Agreement With AccuVein | 34 | 1 |
| Fresenius Medical Care Enters Into An Agreement With NIKKISO | 35 | 1 |
| ThermoGenesis Enters Into Distribution Agreement With Fenwal | 36 | 1 |
| Equity Offering | 37 | 1 |
| Fresenius Plans Private Placement Of Shares For US$1.3 Billion | 37 | 1 |
| Debt Offering | 38 | 1 |
| Fresenius Raises USD300 Million in Private Placement of Notes | 38 | 1 |
| Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 | 39 | 1 |
| Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 | 40 | 1 |
| Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds | 41 | 1 |
| Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million | 42 | 1 |
| Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million | 43 | 1 |
| Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million | 44 | 1 |
| Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million | 45 | 2 |
| Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million | 47 | 1 |
| Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million | 48 | 1 |
| Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million | 49 | 1 |
| Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million | 50 | 1 |
| Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million | 51 | 1 |
| Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million | 52 | 1 |
| Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million | 53 | 2 |
| Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million | 55 | 1 |
| Fresenius Medical Care Completes Private Placement Of Senior Notes For US$360.42 Million | 56 | 1 |
| Asset Transactions | 57 | 1 |
| Fresenius Medical to Divest Dialysis Services Unit in Venezuela | 57 | 1 |
| Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million | 58 | 1 |
| Acquisition | 59 | 1 |
| Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion | 59 | 2 |
| Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine | 61 | 1 |
| Fresenius Medical Care to Acquire Nefrocontrol | 62 | 1 |
| Fresenius Medical Care To Acquire Nikkiso Medical Korea From NIKKISO | 63 | 1 |
| Fresenius SE &Co. KGaA - Key Competitors | 64 | 1 |
| Key Employees | 65 | 1 |
| Locations And Subsidiaries | 66 | 5 |
| Head Office | 66 | 1 |
| Other Locations &Subsidiaries | 66 | 5 |
| Recent Developments | 71 | 1 |
| Strategy And Business Planning | 71 | 1 |
| Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building | 71 | 1 |
| Financial Announcements | 72 | 1 |
| Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter | 72 | 3 |
| May 03, 2016: Strong start into the year Double-digit earnings growth in constant currency Fresenius confirms Group guidance for 2016 | 75 | 2 |
| Feb 24, 2016: Outstanding 2015 financial results 25% dividend increase proposed Positive outlook for 2016 New mid-term growth targets | 77 | 4 |
| Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 | 81 | 2 |
| Apr 29, 2015: Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015 | 83 | 1 |
| Feb 25, 2015: Fresenius Medical Care reports fourth quarter and full year 2014 results | 84 | 3 |
| Corporate Communications | 87 | 1 |
| Jun 26, 2016: Fresenius appoints Stephan Sturm as new Chief Executive Officer Ulf Mark Schneider leaves the company to pursue another opportunity | 87 | 1 |
| Other Significant Developments | 88 | 1 |
| Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago | 88 | 1 |
| Appendix | 89 | 1 |
| Methodology | 89 | 1 |
| About GlobalData | 89 | 1 |
| Contact Us | 89 | 1 |
| Disclaimer | 89 | 1 |